P3 Health Partners Announces Nasdaq’s Confirmation that it has Regained Compliance with Listing Requirements
P3 Health Partners Inc. (NASDAQ: PIII) announced that it has received a Compliance Letter from the Nasdaq Hearing Panel on October 24, 2022, confirming that the company has cured its filing delinquency. This ensures P3 remains compliant with all applicable listing standards and allows its securities to continue trading on Nasdaq. The letter follows the company's filing of its Annual Report for the fiscal year ended December 31, 2021, and two Quarterly Reports, thereby making P3 current in its filing obligations with the U.S. Securities and Exchange Commission.
- Received Compliance Letter from Nasdaq, confirming compliance with listing standards.
- Company's securities will continue to be listed and traded on Nasdaq.
- None.
The Compliance Letter follows the Company’s filing on
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. Words such as "anticipate," "believe," "budget," "contemplate," "continue," "could," "envision," "estimate," "expect," "guidance," "indicate," "intend," "may," "might," "plan," "possibly," "potential," "predict," "probably," "pro-forma," "project," "seek," "should," "target," or "will," or the negative or other variations thereof, and similar words or phrases or comparable terminology, are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the Company’s continued listing on Nasdaq, which reflect the Company’s expectations based upon currently available information and data.
Because such statements are based on the Company’s current expectations and are not statements of fact, actual results may differ materially from those projected or estimated and you are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements, including, but not limited to, the risk that the Company is unable to maintain compliance with the Nasdaq’s continued listing requirements in the future and other factors discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended
View source version on businesswire.com: https://www.businesswire.com/news/home/20221027005251/en/
Investor Relations
Vice President, Investor Relations
kblomquist@p3hp.org
Managing Director
shalper@lifesciadvisors.com
Communications
Executive Vice President, Communications
(904) 415-2744
kbelz@p3hp.org
Source:
FAQ
What does the Compliance Letter from Nasdaq mean for P3 Health Partners (PIII)?
When was the Compliance Letter issued to P3 Health Partners (PIII)?
What filings did P3 Health Partners (PIII) submit to comply with Nasdaq requirements?